NCT05454995View on ClinicalTrials.gov

Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

November 15, 2027

Study Completion Date

November 15, 2027

Conditions
PAD - Peripheral Arterial Disease
Interventions
OTHER

Vessel Restoration System (VRS)

Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)

Trial Locations (1)

Unknown

Flinders Medical Center, Adelaide

Sponsors

Lead Sponsor

Alucent Biomedical
All Listed Sponsors
lead

Alucent Biomedical

INDUSTRY

NCT05454995 - Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II | Biotech Hunter | Biotech Hunter